Author:
Zuo Ling,Ao Guangyu,Wang Yushu,Gao Ming,Qi Xin
Subject
Infectious Diseases,Microbiology (medical)
Reference15 articles.
1. Dominance of alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City;Duerr;J Clin Investig,2021
2. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020
3. A narrative review of the clinical practicalities of Bamlanivimab and Etesevimab antibody therapies for SARS-CoV-2;Nathan;Infect Dis Ther,2021
4. Clinical impact of the early use of monoclonal antibody LY-CoV555 (Bamlanivimab) on mortality and hospitalization among elderly nursing home patients: a multicenter retrospective study;Alam;Cureus,2021
5. Impact of Bamlanivimab monoclonal antibody treatment on hospitalization and mortality among nonhospitalized adults with severe acute respiratory syndrome coronavirus 2 infection;Bariola;Open Forum Infect Dis,2021
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献